NDC 50090-0029

Dilantin

Phenytoin Sodium

Dilantin is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Phenytoin Sodium.

Product ID50090-0029_8657e0f0-e112-44ad-a896-c3ce1b884012
NDC50090-0029
Product TypeHuman Prescription Drug
Proprietary NameDilantin
Generic NamePhenytoin Sodium
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date1976-08-27
Marketing CategoryANDA / ANDA
Application NumberANDA084349
Labeler NameA-S Medication Solutions
Substance NamePHENYTOIN SODIUM
Active Ingredient Strength100 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50090-0029-2

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50090-0029-2)
Marketing Start Date2014-11-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-0029-2 [50090002902]

Dilantin CAPSULE, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA084349
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28

Drug Details

Active Ingredients

IngredientStrength
PHENYTOIN SODIUM100 mg/1

OpenFDA Data

SPL SET ID:f5b7e576-49b1-4633-ab0a-6ab94922e970
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 855673
  • 855671
  • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Cytochrome P450 1A2 Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]
    • Cytochrome P450 2C8 Inducers [MoA]
    • Cytochrome P450 2C19 Inducers [MoA]
    • Cytochrome P450 2D6 Inducers [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • Cytochrome P450 2C9 Inducers [MoA]
    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Cytochrome P450 1A2 Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]
    • Cytochrome P450 2C8 Inducers [MoA]
    • Cytochrome P450 2C19 Inducers [MoA]
    • Cytochrome P450 2D6 Inducers [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • Cytochrome P450 2C9 Inducers [MoA]

    NDC Crossover Matching brand name "Dilantin" or generic name "Phenytoin Sodium"

    NDCBrand NameGeneric Name
    0071-0369DilantinExtended Phenytoin Sodium
    0071-3740DilantinExtended Phenytoin Sodium
    68151-1019DilantinDilantin
    69189-3742DilantinDilantin
    70518-0980DilantinDilantin
    43353-131DilantinDilantin
    50090-0029DilantinDilantin
    0904-6187Extended Phenytoin SodiumPhenytoin Sodium
    10135-603Extended Phenytoin SodiumPhenytoin Sodium
    0378-3750Phenytekphenytoin sodium
    0378-1560Phenytoin Sodiumphenytoin sodium
    0404-9932Phenytoin SodiumPhenytoin Sodium
    0404-9933Phenytoin SodiumPhenytoin Sodium
    0615-1343Phenytoin Sodiumphenytoin sodium
    0615-8020Phenytoin SodiumPhenytoin Sodium
    0641-0493Phenytoin SodiumPhenytoin Sodium
    0641-2555Phenytoin SodiumPhenytoin Sodium
    0641-6138Phenytoin SodiumPhenytoin Sodium
    0641-6139Phenytoin SodiumPhenytoin Sodium
    21695-167Phenytoin SodiumPhenytoin Sodium

    Trademark Results [Dilantin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DILANTIN
    DILANTIN
    71404865 0359292 Live/Registered
    PARKE, DAVIS & COMPANY
    1938-04-04

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.